Latest filing published 23 Jan 2023 for Evelo Biosciences, Inc., €147.
Filing timeline
BuySaleInsider track record
No signal scores available.
Stephen J. Carriere: trading record in brief
Stephen J. Carriere discloses dealings in Evelo Biosciences, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 19 January 2023 and the latest from 23 January 2023.
Every open-market trade on record is a sale: 1 sale worth €147. Besides market trades, the filings include 1 option exercise.
The latest filing, published on 23 January 2023, reports an open-market sale of €147 in Evelo Biosciences, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen J. Carriere
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 151 shares@ US$1.06Common StockSEC:0001694665-23-000002:1
- 354 sharesCommon StockSEC:0001694665-23-000002:0
2 of 2 declarations